Nicholas Piramal India Ltd

Nicholas Piramal India Ltd (NPIL) is part of Piramal Enterprise Ltd (PEL). NPIL Pharma buss is US $ 435 and total PEL buss is US $ 750. NPIL rank no.4 in Indian pharma formulation buss. Top 10 dosage form company in domestic indian pharma market in which NPIL has market share of 4.3%. Partners are Allergan, AMO, Boots, Aventis, Biogen, Chiesi. Acquired Rhodia Uk Inhalation anaesthesia - Halothane & Isofurane. Parenterals - Polygeline. Dermatology - Soap Tetmosol ( for Scabies ) brand acquired from AstraZeneca UK. We have Process R&D and Pharma R&D with a team of 65 scientists each in both R&D with around 25,000 xxxxx each area dedicated for both facility. Have OTC range of products which we plan to Export to various countries under our own (NPIL) brand name and willing to make products for Importing customers who wish to take products under their own brand name.